Prognostic Analysis and Outcomes of Metastatic Pancreatic Cancer Patients Receiving Nab-Paclitaxel Plus Gemcitabine As Second or Later-Line Treatment
Cancer Medicine(2024)
Key words
FOLFIRINOX,gemcitabine,nab-paclitaxel,pancreatic cancer,prognostic model,second-line chemotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined